Cartesian Growth Co. II (NASDAQ:RENE) and Moolec Science (NASDAQ:MLEC) Critical Survey

Moolec Science (NASDAQ:MLEC) and Cartesian Growth Co. II (NASDAQ:RENE) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Volatility and Risk

Moolec Science has a beta of -0.49, indicating that its share price is 149% less volatile than the S&P 500. Comparatively, Cartesian Growth Co. II has a beta of -0.02, indicating that its share price is 102% less volatile than the S&P 500.

Earnings & Valuation

This table compares Moolec Science and Cartesian Growth Co. II”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$5.62 million	5.87	-$7.31 million	($0.20)	-4.29
Cartesian Growth Co. II	N/A	N/A	$11.44 million	N/A	N/A

Cartesian Growth Co. II has lower revenue, but higher earnings than Moolec Science.

Insider & Institutional Ownership

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 59.0% of Cartesian Growth Co. II shares are held by institutional investors. 19.9% of Moolec Science shares are held by insiders. Comparatively, 26.6% of Cartesian Growth Co. II shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Moolec Science and Cartesian Growth Co. II, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	1	0	3.00
Cartesian Growth Co. II	0	0	0	0	0.00

Moolec Science presently has a consensus target price of $6.00, indicating a potential upside of 598.97%. Given Moolec Science’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Moolec Science is more favorable than Cartesian Growth Co. II.

Profitability

This table compares Moolec Science and Cartesian Growth Co. II’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-129.97%	-97.95%	-27.91%
Cartesian Growth Co. II	N/A	-51.08%	5.43%

Summary

Cartesian Growth Co. II beats Moolec Science on 7 of the 11 factors compared between the two stocks.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About Cartesian Growth Co. II

Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.